MelliCell develops technology that studies and uses fat cells to find new treatments for chronic diseases.
MelliCell's investors include LvlUp Ventures, National Science Foundation, National Institute of Diabetes and Digestive and Kidney Diseases.
MelliCell is headquartered in Newton, United States.
MelliCell develops technology that studies and uses fat cells to find new treatments for chronic diseases.
MelliCell is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MelliCell — Funding & Investors." VCBacked, October 28, 2025, https://www.vcbacked.co/company/mellicell. Accessed August 14, 2026.
VCBacked. (2025). MelliCell — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mellicell
{{cite web |title=MelliCell — Funding & Investors |url=https://www.vcbacked.co/company/mellicell |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated